# KENGREAL

NDC: 10122-620
Generic name: cangrelor
Labeler / Manufacturer: Chiesi USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20150708

FDA application: NDA204958

## Active ingredients

- CANGRELOR: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"10122-620"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=10122-620
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=88b434fa-8891-4fd5-9d86-7ea64667c08f